| Therapeutic targeting of the mTOR‐signalling pathway in cancer: benefits and limitations M Moschetta, A Reale, C Marasco, A Vacca, MR Carratù British journal of pharmacology 171 (16), 3801-3813, 2014 | 134 | 2014 |
| Evidence for bone marrow adult stem cell plasticity: properties, molecular mechanisms, negative aspects, and clinical applications of hematopoietic and mesenchymal stem cells … I Catacchio, S Berardi, A Reale, A De Luisi, V Racanelli, A Vacca, R Ria Stem cells international 2013, 2013 | 84 | 2013 |
| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 81 | 2024 |
| Multiple myeloma macrophages: pivotal players in the tumor microenvironment S Berardi, R Ria, A Reale, A De Luisi, I Catacchio, M Moschetta, A Vacca Journal of oncology 2013, 2013 | 75 | 2013 |
| Bone marrow angiogenesis and progression in multiple myeloma R Ria, A Reale, A De Luisi, A Ferrucci, M Moschetta, A Vacca American journal of blood research 1 (1), 76, 2011 | 70 | 2011 |
| Angiogenesis and progression in human melanoma R Ria, A Reale, A Castrovilli, G Mangialardi, F Dammacco, D Ribatti, ... Dermatology research and practice 2010, 2010 | 62 | 2010 |
| Angiogenesis in multiple myeloma A Vacca, R Ria, A Reale, D Ribatti Angiogenesis, Lymphangiogenesis and Clinical Implications 99, 180-196, 2014 | 56 | 2014 |
| Managing myelodysplastic symptoms in elderly patients R Ria, M Moschetta, A Reale, G Mangialardi, A Castrovilli, A Vacca, ... Clinical interventions in aging, 413-423, 2009 | 55 | 2009 |
| Novel agents and new therapeutic approaches for treatment of multiple myeloma R Ria, A Reale, A Vacca World Journal of Methodology 4 (2), 73, 2014 | 52 | 2014 |
| Filgrastim, lenograstim and pegfilgrastim in the mobilization of peripheral blood progenitor cells in patients with lymphoproliferative malignancies R Ria, A Reale, A Melaccio, V Racanelli, F Dammacco, A Vacca Clinical and experimental medicine 15, 145-150, 2015 | 34 | 2015 |
| Functional and biological role of endothelial precursor cells in tumour progression: a new potential therapeutic target in haematological malignancies A Reale, A Melaccio, A Lamanuzzi, I Saltarella, F Dammacco, A Vacca, ... Stem Cells International 2016, 2016 | 33 | 2016 |
| Identify multiple myeloma stem cells: Utopia? I Saltarella, A Lamanuzzi, A Reale, A Vacca, R Ria World journal of stem cells 7 (1), 84, 2015 | 24 | 2015 |
| Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders S Mithraprabhu, M Chen, I Savvidou, A Reale, A Spencer Leukemia 35 (10), 2771-2783, 2021 | 23 | 2021 |
| An evidence-based approach to myeloma bone disease N Bingham, A Reale, A Spencer Current hematologic malignancy reports 12, 109-118, 2017 | 21 | 2017 |
| A retrospective study of skeletal and disease-free survival benefits of zoledronic acid therapy in patients with multiple myeloma treated with novel agents R Ria, A Reale, M Moschetta, G Mangialardi, F Dammacco, A Vacca International Journal of Clinical and Experimental Medicine 6 (1), 30, 2013 | 19 | 2013 |
| Induction therapy and stem cell mobilization in patients with newly diagnosed multiple myeloma R Ria, A Reale, AG Solimando, G Mangialardi, M Moschetta, L Gelao, ... Stem cells international 2012, 2012 | 18 | 2012 |
| Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma R Ria, V Simeon, A Melaccio, G Di Meo, S Trino, C Mazzoccoli, ... Oncotarget 7 (20), 29677, 2016 | 17 | 2016 |
| High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin’s lymphoma MD Ianni, S Ballanti, G Iodice, A Reale, F Falzetti, O Minelli, G Serio, ... Hematology 17 (1), 23-27, 2012 | 17 | 2012 |
| Human myeloma cell‐and plasma‐derived extracellular vesicles contribute to functional regulation of stromal cells A Reale, I Carmichael, R Xu, S Mithraprabhu, T Khong, M Chen, H Fang, ... Proteomics 21 (13-14), 2000119, 2021 | 16 | 2021 |
| High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma F Falzetti, MD Ianni, S Ballanti, G Iodice, A Reale, O Minelli, G Serio, ... Clinical and experimental medicine 12, 165-171, 2012 | 15 | 2012 |
Angelo VACCAUniversità degli Studi di BariVerified email at uniba.it
